# Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer

> **NCT05963100** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Zhongda Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Safety and Efficacy of TCR-like CAR-T

## Interventions

- **BIOLOGICAL:** TCR-like CAR-T

## Key facts

- **NCT ID:** NCT05963100
- **Lead sponsor:** Zhongda Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-07
- **Primary completion:** 2026-05-16
- **Final completion:** 2026-05-16
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05963100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05963100, "Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05963100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*